CYP27A1 and breast carcinoma: In this case expression of CYP27A1 in breast cancer tissue would lead to the deactivation of 3β,5α,6β-triol, however, it should be noted that the biological activity of 3β,5α,6β,26-tetrol and its metabolites have yet to be explored.